CN106692878A - Medicine for treating mammary gland hyperplasia and preparation method of medicine - Google Patents
Medicine for treating mammary gland hyperplasia and preparation method of medicine Download PDFInfo
- Publication number
- CN106692878A CN106692878A CN201710037260.XA CN201710037260A CN106692878A CN 106692878 A CN106692878 A CN 106692878A CN 201710037260 A CN201710037260 A CN 201710037260A CN 106692878 A CN106692878 A CN 106692878A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- rhizoma
- mammary gland
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating mammary gland hyperplasia and a preparation method of the medicine, and relates to medicines for treating mammary gland hyperplasia. The medicine consists of the following raw material medicines in parts by weight: 20-30 parts of angelica sinensis, 20-30 parts of ligusticum wallichii, 20-30 parts of roots of common peony, 20-30 parts of salvia miltiorrhiza, 15-25 parts of peach kernels, 20-30 parts of rhizoma sparganii, 20-30 parts of curcuma zedoary, 20-25 parts of rhizoma corydalis, 15-25 parts of frankincense, 15-25 parts of myth, 15-25 parts of rhizoma cyperi, 5-15 parts of pangolin, 15-25 parts of dear horn pieces, 5-15 parts of rhizoma typhonii, 15-25 parts of ardisia mamillata, 15-25 parts of pinecone, 15-25 parts of ardisia crenata, 15-25 parts of loofah sponge, 15-25 parts of tangerine seeds, 15-25 parts of radix angelicae, 15-25 parts of semen brassicae, 15-25 parts of pinellia ternate, 15-25 parts of dysosma versipellis, 15-25 parts of Chinese violet, 15-25 parts of lonicera japonica, 35-45 parts of dandelion, 5-15 parts of codonopsis pilosula, 5-15 parts of astragalus membranaceus and 1-5 parts of as arum. By adopting the medicine, the purposes of activating blood and removing stasis, clearing and activating the channels and collaterals, relieving swelling and stopping pain, warming to dredge channels and remove stasis and eliminating lumps can be achieved, and the treatment effects of treating diseases from outside can be achieved as livers and intestines and stomachs are not damaged as the medicine is used externally.
Description
Technical field
The present invention relates to a kind of medicine for treating the proliferation of mammary gland, more particularly, to a kind of medicine for treating the proliferation of mammary gland and its
Preparation method.
Background technology
Known, cyclomastopathy is one of adult female's common frdquently encountered disease, and the women of child-bearing age of about 50-60% have not
With the proliferation of mammary gland of degree, 20-45 Sui women is mainly in, onset peak is 35-40 Sui;The characteristics of this is sick be:Mammary gland is constituted into
The hyperplasia divided, exception is shown on structure, quantity and tissue morphology, is caused normal breast leaflet physiological hyperplasia and is returnd to the past not
Entirely, the disorder of mammary gland normal configuration is formed, is the retrogression pathological changes in structure of breast tissue conduit and lobule of mammary gland and is carried out
The growth of property connective tissue.Pathogenic factor is main:It is too high by the estrogen level of ovarian secretion, corpus luteum progestational hormone is very few, or
Both persons secrete uncoordinated, cause the breast ductal epithelial cells in breast and proliferation of fibrous tissue.Cyclomastopathy is faced
Bed performance:Breast pain and lump in breast are principal character, and nipple discharge is also had individually.Breast is with periodicity pain as special
Levy, be originally diffusivity secret anguish or swollen pendant sense, be changed into limitation shouting pain or cutting pains again afterwards, involve side or bilateral breast
Gland;50% hyperplasia is more common in outside upper quadrant, and with tenderness, pain can emit to homonymy upper arm Inner sides, axillary region or lower neck sometimes
Portion;The performance of breast pain is often unstable, the moon is premenstrual, emotional change, it is tired when aggravate;The Tumor size and quality of breast with
Menstrual onset, in cyclically-varying, premenstrual lump increase, quality is harder, the mass reduction after, quality flexible but not hard, swells
Block is in nodositas not of uniform size, unclear with surrounding tissue boundary, and patient is often in the performance that Function of Ovary is disorderly.
The proliferation of mammary gland can divide the fourth phase:
1. hyperplasia of mammary glands(The I phase proliferation of mammary gland)Pure lobular hyperplasia leaflet and intralobular duct number increase, volume increases
Many, marshalling, but leaflet profile still preserves.
2. adenosis of mammary glands(Mammary duct ectasia, the II phase proliferation of mammary gland)Lobule of mammary gland inner catheter number showed increased is small
Interstitial between Ye Yin, leaf(Connective tissue)Increase, occur obvious lymphocyte infiltration around it, or have streak increasing
Raw tissue,
3. cystic hyperplasia(Mammary duct ectasia merges epithelial hyperplasia disease, the III phase proliferation of mammary gland)Proliferation of fibrous tissue exceedes
The hyperplasia of body of gland conduit, makes body of gland disruption catheter, deformation, epithelial cell volume diminish.
4. galactoncus is sick(The IV phase proliferation of mammary gland)There is the epithelium group of obvious expansion, body of gland and conduit in body of gland inner catheter
Active proliferation is knitted, conduit and body of gland occur in that the tumour sample for differing in size changes, full of colourless, skipper and brown in tumour
Liquid, light microscopy can find that entity change occur in conduit and the epithelium of body of gland, or mamillary and sieve-like change, as above
Chrotoplast continues to develop into atypical hyperplasia product skin, then the possibility of mammary gland canceration is larger.Current period mostly occurs in 40-45 Sui capsule
Hyperplasia canceration rate is more than 70%.
At present, domestic 90% proliferation of mammary gland patient recognizes deficiency to cyclomastopathy, does not know about regular treatment with prevention mammary gland
The general knowledge of hyperplasia, thinks little for the treatment of.It is primarily present following several problems:1st, groups of people think that the proliferation of mammary gland need not be treated, energy
Bear and just bear, it is all right after a time;2nd, a little medicines are just used when groups of people think that the proliferation of mammary gland is serious, is not effected a radical cure, during pain of alleviation
Just it is discontinued;3rd, some people drug therapy person, costly, the course for the treatment of is long, easily injures the factors such as stomach, liver, and constrains
Adhere to treatment;4th, proliferation of mammary gland enclosed mass, tubercle, fibroma, tumour patient, hospital's major part is based on surgery excision, and pain is big,
Stay scar, high recurrence rate;So several factors of the above, finally result in the exacerbation of cyclomastopathy, the incidence of breast cancer rises;
Epidemiological studies find that the benign breast disease based on the proliferation of mammary gland is the danger higher of breast cancer relative risk
One of factor;The research of extensive clinical epidemiology is made to Risk Factors of Breast Cancer both at home and abroad, it is believed that cyclomastopathy is special
It is not that atypical hyperplasia is most important hazards, so being treated before treating the change that the proliferation of mammary gland is prevention early-stage breast cancer.
The content of the invention
In order in overcoming the shortcomings of background technology, the invention discloses a kind of medicine for treating the proliferation of mammary gland and its preparation side
Method, realizes promoting blood circulation, clearing and activating the channels and collaterals, swelling and pain relieving, the logical dissipating bind of temperature, eliminates the purpose of lump, and really do by external application
To the not impariment of the liver, do not hinder stomach, reach the curative effect of inner disease outer treat.
In order to realize the goal of the invention, the present invention is adopted the following technical scheme that:
A kind of medicine for treating the proliferation of mammary gland, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 20-30 parts, Ligusticum wallichii 20-30 parts,
Radix paeoniae rubrathe 20-30 parts, red sage root 20-30 parts, peach kernel 15-25 parts, Rhizoma Sparganii 20-30 parts, curcuma zedoary 20-30 parts, corydalis tuber 20-25 parts, breast
It is fragrant 15-25 parts, myrrh 15-25 parts, rhizoma cyperi 15-25 parts, wear front three 5-15 parts, sliced CORNUS CERVI 15-25 parts, rhizoma typhonii 5-15 parts, it is red
Felt 15-25 parts, pinecone 15-25 parts, 15-25 parts of iron sunshade, luffa 15-25 parts, tangerine seed 15-25 parts, root of Dahurain angelica 15-25 parts,
Semen brassicae 15-25 parts, tuber of pinellia 15-25 parts, Dysosma versipellis 15-25 parts, Chinese violet 15-25 parts, two flower 15-25 parts, dandelion 35-
45 parts, Radix Codonopsis 5-15 parts, Radix Astragali 5-15 parts, asarum 1-5 parts.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:22 parts of Radix Angelicae Sinensis, 20 parts of Ligusticum wallichii,
20 parts of the radix paeoniae rubrathe, 20 parts of the red sage root, 15 parts of peach kernel, 15 parts of Rhizoma Sparganii, 15 parts of curcuma zedoary, 20 parts of corydalis tuber, 15 parts of frankincense, 15 parts of myrrh, perfume
Attached 15 parts, wear 5 parts of front three, 15 parts of sliced CORNUS CERVI, 5 parts of rhizoma typhonii, 15 parts of scarlet woollen blanket, 15 parts of the pinecone, 15 parts of iron sunshade, luffa 15
Part, 15 parts of tangerine seed, 17 parts of the root of Dahurain angelica, 17 parts of semen brassicae, 15 parts of the tuber of pinellia, 15 parts of Dysosma versipellis, 17 parts of Chinese violet, two spend 17 parts, Pu
35 parts of public English, 7 parts of Radix Codonopsis, 7 parts of the Radix Astragali, 1 part of asarum.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:25 parts of Radix Angelicae Sinensis, 22 parts of Ligusticum wallichii,
22 parts of the radix paeoniae rubrathe, 23 parts of the red sage root, 18 parts of peach kernel, 17 parts of Rhizoma Sparganii, 17 parts of curcuma zedoary, 22 parts of corydalis tuber, 16 parts of frankincense, 18 parts of myrrh, perfume
Attached 17 parts, wear 8 parts of front three, 18 parts of sliced CORNUS CERVI, 7 parts of rhizoma typhonii, 18 parts of scarlet woollen blanket, 18 parts of the pinecone, 17 parts of iron sunshade, luffa 18
Part, 16 parts of tangerine seed, 19 parts of the root of Dahurain angelica, 19 parts of semen brassicae, 17 parts of the tuber of pinellia, 18 parts of Dysosma versipellis, 18 parts of Chinese violet, two spend 19 parts, Pu
38 parts of public English, 9 parts of Radix Codonopsis, 9 parts of the Radix Astragali, 2 parts of asarum.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:27 parts of Radix Angelicae Sinensis, 27 parts of Ligusticum wallichii,
27 parts of the radix paeoniae rubrathe, 25 parts of the red sage root, 20 parts of peach kernel, 20 parts of Rhizoma Sparganii, 20 parts of curcuma zedoary, 24 parts of corydalis tuber, 22 parts of frankincense, 22 parts of myrrh, perfume
Attached 15 parts, wear 5 parts of front three, 15 parts of sliced CORNUS CERVI, 10 parts of rhizoma typhonii, 18 parts of scarlet woollen blanket, 18 parts of the pinecone, 25 parts of iron sunshade, luffa
25 parts, 22 parts of tangerine seed, 22 parts of the root of Dahurain angelica, 20 parts of semen brassicae, 15 parts of the tuber of pinellia, 19 parts of Dysosma versipellis, 22 parts of Chinese violet, two spend 22 parts,
40 parts of dandelion, 9 parts of Radix Codonopsis, 10 parts of the Radix Astragali, 3 parts of asarum.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:30 parts of Radix Angelicae Sinensis, 28 parts of Ligusticum wallichii,
30 parts of the radix paeoniae rubrathe, 20 parts of the red sage root, 25 parts of peach kernel, 22 parts of Rhizoma Sparganii, 15 parts of curcuma zedoary, 25 parts of corydalis tuber, 15 parts of frankincense, 15 parts of myrrh, perfume
Attached 23 parts, wear 15 parts of front three, 24 parts of sliced CORNUS CERVI, 15 parts of rhizoma typhonii, 25 parts of scarlet woollen blanket, 25 parts of the pinecone, 22 parts of iron sunshade, luffa
22 parts, 15 parts of tangerine seed, 15 parts of the root of Dahurain angelica, 25 parts of semen brassicae, 25 parts of the tuber of pinellia, 22 parts of Dysosma versipellis, 16 parts of Chinese violet, two spend 17 parts,
45 parts of dandelion, 15 parts of Radix Codonopsis, 12 parts of the Radix Astragali, 5 parts of asarum.
A kind of preparation method of the medicine for treating the proliferation of mammary gland, specifically includes following steps:
(1)By Radix Angelicae Sinensis, Ligusticum wallichii, the radix paeoniae rubrathe, the red sage root, peach kernel, Rhizoma Sparganii, curcuma zedoary, corydalis tuber, frankincense, myrrh, rhizoma cyperi, wear front three, deer horn
Piece, rhizoma typhonii, scarlet woollen blanket, the pinecone, iron sunshade, luffa, tangerine seed, the root of Dahurain angelica, semen brassicae, the tuber of pinellia, Dysosma versipellis, Chinese violet, two
Flower, dandelion, Radix Codonopsis, the Radix Astragali, asarum are put into marmite, add water 7000 milliliters it is boiled, be cooked by slow fire 1.5-2 hours, it is fried
4500-4800 milliliters of concoction;
(2)Previous step is connect, the concoction in previous step is poured into medicine kettle, and is put into sterile gauze pad and boiled, pad of cotion is dragged for
Go out waiting temperature for 30-50 spend when, being placed on the breast affected area of patient carries out external application, and the external application time is 30-50 minutes, daily one
It is secondary.
By adopting the above-described technical solution, the present invention has the advantages that:
The pharmacological action of each Chinese medicine:
Radix Angelicae Sinensis:Enhancing is immune, anti-inflammatory, benefiting blood and regulating blood circulation, effectively regulation immunity of organisms, antitumor;
Ligusticum wallichii:Blood-activating and qi-promoting, wind-expelling pain-stopping, effectively alleviate hypochondriac pain, liver blood stasis, accumulation lump in the abdomen, the chest side of body shouting pain of stagnation of QI due to depression of the liver;
The radix paeoniae rubrathe:Clearing heat and cooling blood, blood stasis removing analgesic.For red eye, swell pain, liver-depressed hypochondrium pain, closed dysmenorrhea, abdominal mass is suffered from abdominal pain, injury from falling down,
Carbuncle swells sore;
The red sage root:Promoting blood circulation, nourishing blood and tranquilization, cool blood detumescence;
Peach kernel:Promoting blood circulation, relaxes bowel;
Rhizoma Sparganii:Blood-breaking, promoting the circulation of qi, disperse accumulations, analgesic;
Curcuma zedoary:Blood-breaking analgesic, gas consumption product analgesic, dissipating blood stasis with potent drugs;
Corydalis tuber:Promoting blood circulation, sharp gas, analgesic, for each portion's qi depression to blood stasis of whole body pain;
Frankincense:Can regulating qi and activating blood, analgesic therapy, chase after poison, treat ulcerative carbuncle pyogenic infections, spices can be made;
Myrrh:Dissipate blood and dissolving stasis, detumescence ding-tong;
Rhizoma cyperi:Regulating the flow of vital energy Xie Yu, menstruction regulating and pain relieving;
Wear front three:It is good at walking to alter, row dissipates, and eliminating stasis and resolving masses are promoting blood circulation and removing obstruction in channels, detumescence and apocenosis;Stimulate the menstrual flow lower breast;
Sliced CORNUS CERVI:Kidney-replenishing, benefiting essence-blood.Promoting circulation of blood is subsided a swelling, astringing to arrest bleeding.Specially control acute mastitis swell and ache, sore carbuncle obstinate, with anti-inflammatory
Function;
Rhizoma typhonii:Powder detoxifcation;
Scarlet woollen blanket:Clearing heat and promoting diuresis, promoting blood circulation and hemostasis, remove necrosis and promote granulation;
The pinecone:Eliminating the phlegm, cough-relieving, relieving asthma, anti-inflammatory;
Iron sunshade:Removing toxic substances promoting blood circulation;Swelling and pain relieving, swollen ulcer drug;
Luffa:It is clearing and activating the channels and collaterals, clearing heat and detoxicating, inducing diuresis to remove edema, hemostasis;Cure mainly distending pain in the chest and hypochondrium, arthralgia pain due to rheumatism, muscle arteries and veins contraction, female
Sub- Amenorrhea, alactation, heat toxin carbuncle swells;
Tangerine seed:Qi-regulating, analgesic;
The root of Dahurain angelica:Apocenosis of invigorating blood circulation;
Semen brassicae:Sharp gas slit phlegm, warming spleen and stomach for dispelling cold is removed obstruction in channels to relieve pain;
The tuber of pinellia:Blood stasis removing analgesic, removing toxicity for detumescence, treatment acute mastitis, sore carbuncle furuncle;
Dysosma versipellis:Reducing phlegm and resolving masses, stasis-dispelling and pain-killing, clearing heat and detoxicating, carbuncle swells, furunculosis, venomous snake bite, traumatic injury;
Chinese violet:Clearing heat and detoxicating, cool blood detumescence, the effect of clearing heat and promoting diuresis cures mainly furunculosis, carbuncle swells;
Two flowers:It is clearing heat and detoxicating, cure mainly warm disease heating, toxic-heat and blood stasis, ulcer serious case of furuncle, with antibacterial action;
Dandelion:It is clearing heat and detoxicating, carbuncle that disappears dissipating bind,;
Radix Codonopsis:Bowl spares, QI invigorating is promoted the production of body fluid;
The Radix Astragali:Invigorating qi for strengthening superficies, diuretic and maintain drug, apocenosis, expelling pus and promoting granulation;
Asarum:With obvious antiinflammatory action, warming the middle warmer and descending qi, open in the heart, it is lower breast knot;
The beneficial effect that technical scheme is brought:
Medicine of the invention has promoting blood circulation, clearing and activating the channels and collaterals, swelling and pain relieving, the logical dissipating bind of temperature, eliminates lump;It is real by external application
Accomplish the not impariment of the liver, do not hinder stomach, reach the curative effect of inner disease outer treat, promote local blood circulation, accelerate metabolism, adjust human body
The function such as absorption, conduction, balance, metabolism, immune, exclusion human breast physiological waste, the wet, stasis of blood, heat, poison promote passages through which vital energy circulates qi and blood
Normal operation, so as to balance endocrine, suppresses fibre deformation, promotion organization cell repair;The application by by Radix Angelicae Sinensis and Ligusticum wallichii,
The radix paeoniae rubrathe, peach kernel, the red sage root are used cooperatively, and with replenishing and activating blood, strengthen promoting blood circulation, the effect of analgesic;Radix Codonopsis is matched somebody with somebody with the Radix Astragali, Radix Angelicae Sinensis
Conjunction is used, with rich in nutrition, the effect of benefiting qi for promoting production of blood;Radix Angelicae Sinensis, the radix paeoniae rubrathe, frankincense, myrrh are used cooperatively, with promoting blood circulation to remove blood stasis,
The effect of swelling and pain relieving;Rhizoma Sparganii, curcuma zedoary are used cooperatively, with promoting blood circulation, softening and resolving hard mass, promoting the circulation of qi, disperse accumulations, analgesic, myogenic, is resisted
Tumour, two medicine compatibilities promote the lump and fiber of the proliferation of mammary gland to absorb, and can terminate or reverse this sick pathological change;By frankincense, do not have
Medicine is used cooperatively, with frankincense promoting blood circulation, myrrh dissipate blood effect, the two mutually and and uses, all can swelling and pain relieving, temperature lead to dissipating bind, corruption of dispelling
Myogenic;The radix paeoniae rubrathe is used with the red sage root, peach kernel, Radix Angelicae Sinensis, two flowers, promoting blood circulation and removing blood stasis, clearing heat and detoxicating, the logical dissipating bind of temperature specially controls sore, carbuncle and painful swelling;
Rhizoma cyperi dispersing stagnated hepatoqi, menstruction regulating and pain relieving specially controls swollen breasts with tangerine seed, dandelion, the radix paeoniae rubrathe;The red sage root, two flowers, frankincense, pangolin its
Clearing heat and detoxicating, acute mastitis is specially controlled in promoting blood circulation to remove blood stasis detumescence;The root of Dahurain angelica, with dandelion, with mass dissipating and swelling eliminating, relieve pain the effect of myogenic;Corydalis tuber
With the red sage root, myrrh, with promoting blood circulation, promoting qi circulation and relieving pain;Chinese violet, dandelion, two flower, uniformly have the effect of it is clearing heat and detoxicating,
It is more preferable with the use of effect;Asarum is pungent, warm with rhizoma typhonii fitness for use, thoughts of returning home warp, and asarum controls table, and monkshood controls interior, the warm soil of warm kidney, with
Aid yang qi, aproll gas, the two simultaneously uses warming and activating meridian, eliminating cold to stop pain.Applicable crowd is:1st, mammary gland maintenance, conditioning and the U.S. breast of chest enlarge
Person;2nd, mammary gland turgor, pain, discomfort person when menstruation comes;3rd, milk residual needs latex dust to dredge health person;4th, secondary breast person;5th, suffer from
The proliferation of mammary gland, mammary gland nodules, Breast Nodules, galactoncus, mammary gland fibroma.It is of the invention to be verified by clinical practice, invariably
Good reaction, and medicine of the invention is 81% in more than ten thousand example clinical cure rates, total effective rate is 92%.
Specific embodiment
Explanation that can be detailed by the following examples is of the invention, and the open purpose of the present invention is intended to protect model of the present invention
Enclose all interior technological improvements.
The medicine of the present invention treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 20-30 parts, Ligusticum wallichii 20-
30 parts, radix paeoniae rubrathe 20-30 parts, red sage root 20-30 parts, peach kernel 15-25 parts, Rhizoma Sparganii 20-30 parts, curcuma zedoary 20-30 parts, corydalis tuber 20-25
Part, frankincense 15-25 parts, myrrh 15-25 parts, rhizoma cyperi 15-25 parts, wear front three 5-15 parts, sliced CORNUS CERVI 15-25 parts, rhizoma typhonii 5-15
Part, scarlet woollen blanket 15-25 parts, pinecone 15-25 parts, 15-25 parts of iron sunshade, luffa 15-25 parts, tangerine seed 15-25 parts, root of Dahurain angelica 15-
25 parts, semen brassicae 15-25 parts, tuber of pinellia 15-25 parts, Dysosma versipellis 15-25 parts, Chinese violet 15-25 parts, two flower 15-25 parts, Pu Gong
English 35-45 parts, Radix Codonopsis 5-15 parts, Radix Astragali 5-15 parts, asarum 1-5 parts.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:22 parts of Radix Angelicae Sinensis, 20 parts of Ligusticum wallichii,
20 parts of the radix paeoniae rubrathe, 20 parts of the red sage root, 15 parts of peach kernel, 15 parts of Rhizoma Sparganii, 15 parts of curcuma zedoary, 20 parts of corydalis tuber, 15 parts of frankincense, 15 parts of myrrh, perfume
Attached 15 parts, wear 5 parts of front three, 15 parts of sliced CORNUS CERVI, 5 parts of rhizoma typhonii, 15 parts of scarlet woollen blanket, 15 parts of the pinecone, 15 parts of iron sunshade, luffa 15
Part, 15 parts of tangerine seed, 17 parts of the root of Dahurain angelica, 17 parts of semen brassicae, 15 parts of the tuber of pinellia, 15 parts of Dysosma versipellis, 17 parts of Chinese violet, two spend 17 parts, Pu
35 parts of public English, 7 parts of Radix Codonopsis, 7 parts of the Radix Astragali, 1 part of asarum.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:25 parts of Radix Angelicae Sinensis, 22 parts of Ligusticum wallichii,
22 parts of the radix paeoniae rubrathe, 23 parts of the red sage root, 18 parts of peach kernel, 17 parts of Rhizoma Sparganii, 17 parts of curcuma zedoary, 22 parts of corydalis tuber, 16 parts of frankincense, 18 parts of myrrh, perfume
Attached 17 parts, wear 8 parts of front three, 18 parts of sliced CORNUS CERVI, 7 parts of rhizoma typhonii, 18 parts of scarlet woollen blanket, 18 parts of the pinecone, 17 parts of iron sunshade, luffa 18
Part, 16 parts of tangerine seed, 19 parts of the root of Dahurain angelica, 19 parts of semen brassicae, 17 parts of the tuber of pinellia, 18 parts of Dysosma versipellis, 18 parts of Chinese violet, two spend 19 parts, Pu
38 parts of public English, 9 parts of Radix Codonopsis, 9 parts of the Radix Astragali, 2 parts of asarum.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:27 parts of Radix Angelicae Sinensis, 27 parts of Ligusticum wallichii,
27 parts of the radix paeoniae rubrathe, 25 parts of the red sage root, 20 parts of peach kernel, 20 parts of Rhizoma Sparganii, 20 parts of curcuma zedoary, 24 parts of corydalis tuber, 22 parts of frankincense, 22 parts of myrrh, perfume
Attached 15 parts, wear 5 parts of front three, 15 parts of sliced CORNUS CERVI, 10 parts of rhizoma typhonii, 18 parts of scarlet woollen blanket, 18 parts of the pinecone, 25 parts of iron sunshade, luffa
25 parts, 22 parts of tangerine seed, 22 parts of the root of Dahurain angelica, 20 parts of semen brassicae, 15 parts of the tuber of pinellia, 19 parts of Dysosma versipellis, 22 parts of Chinese violet, two spend 22 parts,
40 parts of dandelion, 9 parts of Radix Codonopsis, 10 parts of the Radix Astragali, 3 parts of asarum.
The medicine of the described treatment proliferation of mammary gland, is made up of the bulk drug of following weight portion:30 parts of Radix Angelicae Sinensis, 28 parts of Ligusticum wallichii,
30 parts of the radix paeoniae rubrathe, 20 parts of the red sage root, 25 parts of peach kernel, 22 parts of Rhizoma Sparganii, 15 parts of curcuma zedoary, 25 parts of corydalis tuber, 15 parts of frankincense, 15 parts of myrrh, perfume
Attached 23 parts, wear 15 parts of front three, 24 parts of sliced CORNUS CERVI, 15 parts of rhizoma typhonii, 25 parts of scarlet woollen blanket, 25 parts of the pinecone, 22 parts of iron sunshade, luffa
22 parts, 15 parts of tangerine seed, 15 parts of the root of Dahurain angelica, 25 parts of semen brassicae, 25 parts of the tuber of pinellia, 22 parts of Dysosma versipellis, 16 parts of Chinese violet, two spend 17 parts,
45 parts of dandelion, 15 parts of Radix Codonopsis, 12 parts of the Radix Astragali, 5 parts of asarum.
A kind of preparation method of the medicine for treating the proliferation of mammary gland, specifically includes following steps:
(1)By Radix Angelicae Sinensis, Ligusticum wallichii, the radix paeoniae rubrathe, the red sage root, peach kernel, Rhizoma Sparganii, curcuma zedoary, corydalis tuber, frankincense, myrrh, rhizoma cyperi, wear front three, deer horn
Piece, rhizoma typhonii, scarlet woollen blanket, the pinecone, iron sunshade, luffa, tangerine seed, the root of Dahurain angelica, semen brassicae, the tuber of pinellia, Dysosma versipellis, Chinese violet, two
Flower, dandelion, Radix Codonopsis, the Radix Astragali, asarum are put into marmite, add water 7000 milliliters it is boiled, be cooked by slow fire 1.5-2 hours, it is fried
4500-4800 milliliters of concoction;
(2)Previous step is connect, the concoction in previous step is poured into medicine kettle, and is put into sterile gauze pad and boiled, pad of cotion is dragged for
Go out waiting temperature for 30-50 spend when, the breast affected area for being placed on patient carries out external application.The external application time is 30-50 minutes, daily one
It is secondary.
Embodiment:
Choose 250 patients counted, patient age between 28-45 Sui, the course of disease -8 years 2 months, all patients have not
With the breast diffusivity secret anguish or distending pain symptom of degree, B surpasses the visible different degrees of proliferation of mammary gland of inspection, and quality is medium, border
It is unclear;Shown through tested patient census' result, up to 98%, cure rate is 95% to treated effect;
Specific embodiment is as follows:
Embodiment 1
Cui XX, female, 43 years old age, Luoyang City Luoning County Xincheng District, consultation time:2014.7.16;
Patient's bilateral breast hyperplasia more than 20 years, once made a definite diagnosis to the Second Academy of Luoyang City, three institutes, the ultrasound diagnosis of mastosis hospital:Bilateral breast
Gland hyperplasia;Medication treatment, when it is light when weight, bilateral breast diffusivity secret anguish with menstrual cycle property change, before menstrual onset aggravate, the moon
Mitigate after stop over, do not cure always;In this year bilateral breast pain aggravate, premenstrua and it is excited when it is heavier, influence
Sleep;Palpation:The accessible graininess that differs in size of bilateral breast, lumps enclosed mass, surface are smooth, clear border, form rule,
Substantially, preferably, matter is harder and uniform, and skin and substrate are without adhesion for mobility for tenderness.Peripheral lymphoid not enlargement.
Chemical examination:1. carcinomebryonic antigen(-)2. sugar antigen CA153 quantifies 5u/ml;
B ultrasonic:Bilateral breast hyperplasia;
Diagnosis:Bilateral breast hyperplasia;
The medicine of the proliferation of mammary gland is treated, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 22g, Ligusticum wallichii 20g, radix paeoniae rubrathe 20g, the red sage root
20g, peach kernel 15g, Rhizoma Sparganii 15g, curcuma zedoary 15g, corydalis tuber 20g, frankincense 15g, myrrh 15g, rhizoma cyperi 15g, wear front three 5g, sliced CORNUS CERVI
15g, rhizoma typhonii 5g, scarlet woollen blanket 15g, pinecone 15g, iron sunshade 15g, luffa 15g, tangerine seed 15g, root of Dahurain angelica 17g, semen brassicae 17g,
Tuber of pinellia 15g, Dysosma versipellis 15g, Chinese violet 17g, two flower 17g, dandelion 35g, Radix Codonopsis 7g, Radix Astragali 7g, asarum 1g.
Preparation method:Said medicine is put into marmite, add water 7000 milliliters it is boiled, be cooked by slow fire 1.5-2 hours, it is fried
4500-4800 milliliters of concoction;Concoction is poured into medicine kettle, and is put into sterile gauze and boiled, pull gauze out waiting temperature for 30-
At 50 degree, being placed on the breast affected area of patient carries out external application, and the external application time is 30-50 minutes, once a day.
Treatment record:
First course for the treatment of:On July 6th, 2014 starts the-end of day of July 15;Whole breast softens, part enclosed mass reduces, reduction, breast
Room pain relief;
Second course for the treatment of:July 19 in 2014 starts the-end of day of July 28;Bilateral breast enclosed mass is most of to dissipate, and breast pain disappears
Lose;
3rd end of day of 3-August of August 12 of the course for the treatment of 2014;Palpation:Bilateral breast does not touch enclosed mass phenomenon.Ultrasound diagnosis bilateral
Mammary gland no abnormality seen.
Check health care:
For the first time:The health therapy on the 13rd of 11-September of September in 2014, palpation bilateral breast no abnormality seen;
Second:12-October 14 October in 2014 health therapy, palpation bilateral breast no abnormality seen;
For the third time:13-November 15 November in 2014 health therapy, palpation bilateral breast no abnormality seen;
Follow-up:No. 16 return visits in 2 months 2016, bilateral breast no abnormality seen.
Embodiment 2
Normal XX, female, 46 years old, Luoyang City Long Xiang Easts, consultation time September in 2015 12 days;
Patient's bilateral breast hyperplasia more than 15 years, when once to Beijing, Shanghai, the Luoyang Second Academy, three institute City Hospitals diagnosis, medication treatment
Weight when light, fails to cure;Bilateral breast pain is aggravated over the nearly moon, and enclosed mass gradually increases, increases, and influences normal life, particularly
Premenstrua and it is excited when more very;Palpation:Accessible more than 10 enclosed mass of number that differ in size of bilateral breast, in lumps,
Streak, form is relatively regular, and substantially, preferably, skin and substrate are without adhesion, and matter is harder and uniform, reality enclosed mass for mobility for tenderness,
Axillary lymph not enlargement.The maximum accessible about 2.8*2.6cm enclosed mass of left breast outside upper quadrant, outside upper, LIQ is maximum can
Touch about 2.0*1.7cm, enclosed mass, the interior maximum accessible about 2.1*1.8cm enclosed mass of upper, LIQ.Right breast is outside upper, it is interior on
The maximum accessible 2.2*1.8cm enclosed mass of quadrant.
Chemical examination:1. carcinomebryonic antigen(-)2. sugar antigen CA153 quantifies 17u/ml;
B ultrasonic:1. the bilateral breast tubercle of bilateral breast hyperplasia 2.;
Diagnosis:1. the bilateral breast enclosed mass of bilateral breast hyperplasia 2..
The medicine of the proliferation of mammary gland is treated, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 27g, Ligusticum wallichii 27g, radix paeoniae rubrathe 27g,
Red sage root 25g, peach kernel 20g, Rhizoma Sparganii 20g, curcuma zedoary 20g, corydalis tuber 22g, frankincense 22g, myrrh 22g, rhizoma cyperi 15g, wear front three 5g, deer
Gusset plate 15g, rhizoma typhonii 10g, scarlet woollen blanket 18g, pinecone 18g, iron sunshade 25g, luffa 25g, tangerine seed 22g, root of Dahurain angelica 22g, sinapsis alba
Sub- 20g, tuber of pinellia 15g, Dysosma versipellis 19g, Chinese violet 22g, two flower 22g, dandelion 40g, Radix Codonopsis 9g, Radix Astragali 10g, asarum 3g.
Preparation method is with embodiment 1;
Treatment:
First course for the treatment of:September starts the-end of day of October 3 on the 24th within 2015.Whole breast softens, enclosed mass reduces, reduction;
Second course for the treatment of:On October 7th, 2015 starts the-end of day of October 16;Breast occurred in October 11 phenomenon of itching, and is breast
Symptom is repaired, is disappeared automatically after 3 days;Bilateral breast enclosed mass is most of to be reduced, reduces;The accessible maximum enclosed mass of bilateral breast is
1.4*1.0cm phenomenons;
3rd course for the treatment of:On October 20th, 2015 starts the-end of day of October 29;Bilateral breast enclosed mass is most of to be reduced, reduces, double
Mammary gland accessible maximum enclosed mass in side is 0.7*0.4cm phenomenons;
4th course for the treatment of:On November 2nd, 2015 starts the-end of day of November 11;Palpation:The accessible maximum enclosed mass of bilateral breast is
0.3*0.3cm phenomenons;
5th course for the treatment of:On November 2nd, 2015 starts the-end of day of November 11;Palpation:Bilateral breast does not touch enclosed mass phenomenon;B
It is super to check bilateral breast no abnormality seen.
Check:
For the first time:12 days-December 14 December in 2015 health therapy, palpation bilateral breast no abnormality seen;
Second:15 days-December 17 January in 2016 health therapy, palpation bilateral breast no abnormality seen;
For the third time:On 2 18th, 2016 health therapies, palpation bilateral breast no abnormality seen;
Follow-up:In December, 2016 No. 6 comes to visit, bilateral breast no abnormality seen.
Embodiment 3
History XX, female, 55 years old, Luoyang City Hongshan District, consultation time September in 2015 19 days;
Patient's bilateral breast hyperplasia more than 5 years, once made a definite diagnosis to the Luoyang Second Academy, three institute's City Hospitals, mastosis examination in hospital, took medicine
Treatment, when it is light when weight, do not cure always.Bilateral breast diffusivity secret anguish is aggravated over the nearly moon, premenstrua and it is excited when more
Weight, enclosed mass gradually increases, increases, and influences normal life.Palpation:The accessible graininess that differs in size of bilateral breast, lumps swell
Block, form is relatively regular, and substantially, preferably, skin and substrate are without adhesion, and matter is harder and uniform, reality enclosed mass for mobility, surrounding for tenderness
Lymph not enlargement.The left side maximum accessible about 2.0*1.8cm lumps of mammary gland outside upper quadrant, outside upper, UIQ is maximum accessible
About 2..3*2.0cm lumps, it is interior under, the maximum accessible about 1.8*1.6cm lumps of LOQ.Right breast outside upper quadrant is maximum
Accessible 2.0*1.9cm lumps.
Chemical examination:1. carcinomebryonic antigen(-)2. sugar antigen CA153 quantifies 8u/ml;
B ultrasonic:1. the bilateral breast tubercle of bilateral breast hyperplasia 2.;
Diagnosis:1. the bilateral breast enclosed mass of bilateral breast hyperplasia 2..
The medicine of the proliferation of mammary gland is treated, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 25g, Ligusticum wallichii 22g, radix paeoniae rubrathe 22g,
Red sage root 23g, peach kernel 18g, Rhizoma Sparganii 17g, curcuma zedoary 17g, corydalis tuber 24g, frankincense 16g, myrrh 18g, rhizoma cyperi 17g, wear front three 8g, deer
Gusset plate 18g, rhizoma typhonii 7g, scarlet woollen blanket 18g, pinecone 18g, iron sunshade 17g, luffa 18g, tangerine seed 16g, root of Dahurain angelica 19g, semen brassicae
19g, tuber of pinellia 17g, Dysosma versipellis 18g, Chinese violet 18g, two flower 19g, dandelion 38g, Radix Codonopsis 9g, Radix Astragali 9g, asarum 2g.
Preparation method is with embodiment 1;
Treatment:
First course for the treatment of:September starts the-end of day of September 28 on the 19th within 2015.Whole breast softens, enclosed mass reduces, reduction;
Second course for the treatment of:On October 1st, 2015 starts the-end of day of October 10;Bilateral breast enclosed mass is most of to be reduced, reduces 50;It is double
Mammary gland accessible maximum enclosed mass in side is 1.0*0.9cm;
3rd course for the treatment of:On October 14th, 2015 starts the-end of day of October 23;Bilateral breast enclosed mass is most of to be reduced, it is small to reduce,
The accessible maximum enclosed mass of 90 bilateral breasts is reduced for 0.3*0.2cm;
The end of day of 4th on the November 27 ,-December of the course for the treatment of 2015 6;Palpation:Bilateral breast does not touch enclosed mass phenomenon;Ultrasound diagnosis
Bilateral breast no abnormality seen.
Check:
For the first time:6 days-January 8 January in 2016 health therapy, palpation bilateral breast no abnormality seen;
Second:11 days -2 months on 2 9th, 2016 health therapies, palpation bilateral breast no abnormality seen;
For the third time:12 days-March 14 March in 2016 health therapy, palpation bilateral breast no abnormality seen;
Follow-up:September 16 is come to visit within 2016, bilateral breast no abnormality seen.
Embodiment 4
Feng XX, female, 55 years old age, Luoyang City Jianxi District, consultation time on July 6th, 2016;
Patient's bilateral breast hyperplasia more than 5 years, once made a definite diagnosis to the Second Academy of Luoyang City, institute of traditional Chinese medicine, molybdenum target inspection:1. bilateral breast hyperplasia
2. bilateral breast tumour;Medication treatment, when it is light when weight, lump with menstrual cycle property change, menstrual onset lump increase, the moon stop over
Mass reduction afterwards;Do not cure always;The shouting pain of bilateral breast continuation is aggravated over the nearly moon, premenstrua and it is excited when it is heavier,
Enclosed mass gradually increases, increases, and influences normal life;Palpation:The accessible round granular that differs in size of bilateral breast, nodositas swell
Block, surface is smooth, clear border, has capsule sexy, and form is slightly irregular, and substantially, mobility is poor, and matter is harder and uniform for tenderness,
Capsule enclosed mass;Peripheral lymphoid not enlargement.The left side maximum accessible about 2.6*2.6 lumps of mammary gland outside upper quadrant.Right breast is outside upper
The maximum accessible 3.2*3.0 lumps of quadrant.
Chemical examination:1. carcinomebryonic antigen(-)2. sugar antigen CA153 quantifies 15u/ml;
B ultrasonic:1. the bilateral breast tubercle of 2. bilateral breast tumour of bilateral breast hyperplasia 3.;
Diagnosis:1. the bilateral breast tumour of bilateral breast hyperplasia 2..3. bilateral breast tubercle;
The medicine of the proliferation of mammary gland is treated, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 30g, Ligusticum wallichii 28g, radix paeoniae rubrathe 30g, the red sage root
20g, peach kernel 25g, Rhizoma Sparganii 22g, curcuma zedoary 15g, corydalis tuber 25g, frankincense 15g, myrrh 15g, rhizoma cyperi 23g, wear front three 15g, deer horn
Piece 24g, rhizoma typhonii 15g, scarlet woollen blanket 25g, pinecone 25g, iron sunshade 22g, luffa 22g, tangerine seed 15g, root of Dahurain angelica 15g, semen brassicae
25g, tuber of pinellia 25g, Dysosma versipellis 22g, Chinese violet 16g, two flower 17g, dandelion 45g, Radix Codonopsis 15g, Radix Astragali 12g, asarum 5g.
Preparation method is with embodiment 1;
Treatment:
First course for the treatment of:On July 6th, 2016 starts the-end of day of July 15;Whole breast softens, enclosed mass reduces, reduction;
Second course for the treatment of:On July 19th, 2016 starts the-end of day of July 28;Bilateral breast enclosed mass is most of to be reduced, reduces, bilateral
The accessible maximum enclosed mass of mammary gland is 1.0*1.0cm;
3rd course for the treatment of:August starts the-end of day of August 10 on the 1st within 2016;Bilateral breast enclosed mass is most of to be reduced, reduces, bilateral breast
The accessible maximum enclosed mass of gland is 0.5*0.5cm;
The end of day of 4th 14 days-August of the August of the course for the treatment of 2016 23;Palpation:Bilateral breast does not touch enclosed mass phenomenon, ultrasound diagnosis
Bilateral breast no abnormality seen.
Check:
For the first time:22 days-September the health therapy on the 25th of September in 2016, palpation bilateral breast no abnormality seen;
Second:24 days-October 26 October in 2016 health therapy, palpation bilateral breast no abnormality seen;
For the third time:25 days-November 27 November in 2016 health therapy, palpation bilateral breast no abnormality seen;
Follow-up:No. 12 checks of in January, 2017, bilateral breast no abnormality seen.
Embodiment 5
Open XX, female, age 55, Luoyang City Luolong District, consultation time on March 18th, 2016;
The patient makes a definite diagnosis in the Second Academy of Luoyang City health examination, molybdenum target inspection:Right side breast fibroma 3.8*3.8 cm suggestion operations
Excision;Palpation:The accessible about 3.8*3. 8cm circles isolated mass of right side breast outside upper quadrant, surface is smooth, and clear border has
It is real sexy, form rule, without tenderness, mobility is good, and matter is hard and uniform, reality enclosed mass;Peripheral lymphoid not enlargement.
Chemical examination:1. carcinomebryonic antigen(-)2. sugar antigen CA153 quantifies 6u/ml;
Molybdenum target:Right breast fibroma;
Diagnosis:Right breast fibroma;
The medicine of the proliferation of mammary gland is treated, is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 30g, Ligusticum wallichii 28g, radix paeoniae rubrathe 30g, the red sage root
20g, peach kernel 25g, Rhizoma Sparganii 22g, curcuma zedoary 15g, corydalis tuber 25g, frankincense 15g, myrrh 15g, rhizoma cyperi 23g, wear front three 15g, deer horn
Piece 24g, rhizoma typhonii 15g, scarlet woollen blanket 25g, pinecone 25g, iron sunshade 22g, luffa 22g, tangerine seed 15g, root of Dahurain angelica 15g, semen brassicae
25g, tuber of pinellia 25g, Dysosma versipellis 22g, Chinese violet 16g, two flower 17g, dandelion 45g, Radix Codonopsis 15g, Radix Astragali 12g, asarum 5g.
Treatment:
First course for the treatment of:On March 18th, 2016 starts the-end of day of March 27, right breast fibroma 2.5*2.5 cm;
Second course for the treatment of:On March 31st, 2016 starts the-end of day of April 9, and right breast fibroma is reduced into 1.8.*1.8cm;
3rd course for the treatment of:2016.4.13-4.22 end are started, right breast fibroma is reduced into 0.6*0.6cm;
The end of day palpation of 4th on the April 26 ,-May of the course for the treatment of 2016 5:Bilateral breast does not touch enclosed mass phenomenon, ultrasound diagnosis
Bilateral breast no abnormality seen.
Check:
For the first time:4 days-June 6 June in 2016 health therapy, palpation bilateral breast no abnormality seen.
Second:5 days-July 7 July in 2016 health therapy, palpation bilateral breast no abnormality seen.
For the third time:6 days-August the health therapy on the 8th of August in 2016, palpation bilateral breast no abnormality seen.
Follow-up:No. 9 checks of in January, 2017, bilateral breast no abnormality seen.
Part not in the detailed description of the invention is prior art.
The embodiment selected herein for the open purpose of the present invention, is presently considered to be suitable, but, Ying Liao
Solution, it is contemplated that all changes for belonging to the embodiment in this design and invention scope including all and improvement.
Claims (6)
1. a kind of medicine for treating the proliferation of mammary gland, it is characterized in that:It is made up of the bulk drug of following weight portion:Radix Angelicae Sinensis 20-30 parts, river
Rhizome of chuanxiong 20-30 parts, radix paeoniae rubrathe 20-30 parts, red sage root 20-30 parts, peach kernel 15-25 parts, Rhizoma Sparganii 20-30 parts, curcuma zedoary 20-30 parts, corydalis tuber
20-25 parts, frankincense 15-25 parts, myrrh 15-25 parts, rhizoma cyperi 15-25 parts, wear front three 5-15 parts, sliced CORNUS CERVI 15-25 parts, rhizoma typhonii
5-15 parts, scarlet woollen blanket 15-25 parts, pinecone 15-25 parts, 15-25 parts of iron sunshade, luffa 15-25 parts, tangerine seed 15-25 parts, the root of Dahurain angelica
15-25 parts, semen brassicae 15-25 parts, tuber of pinellia 15-25 parts, Dysosma versipellis 15-25 parts, Chinese violet 15-25 parts, two flower 15-25 parts,
Dandelion 35-45 parts, Radix Codonopsis 5-15 parts, Radix Astragali 5-15 parts, asarum 1-5 parts.
2. it is according to claim 1 treatment the proliferation of mammary gland medicine, it is characterized in that:By the bulk drug group of following weight portion
Into:22 parts of Radix Angelicae Sinensis, 20 parts of Ligusticum wallichii, 20 parts of the radix paeoniae rubrathe, 20 parts of the red sage root, 15 parts of peach kernel, 15 parts of Rhizoma Sparganii, 15 parts of curcuma zedoary, 20 parts of corydalis tuber,
15 parts of frankincense, 15 parts of myrrh, 15 parts of rhizoma cyperi, wear 5 parts of front three, 15 parts of sliced CORNUS CERVI, 5 parts of rhizoma typhonii, 15 parts of scarlet woollen blanket, the pinecone 15
Part, 15 parts of iron sunshade, 15 parts of luffa, 15 parts of tangerine seed, 17 parts of the root of Dahurain angelica, 17 parts of semen brassicae, 15 parts of the tuber of pinellia, 15 parts of Dysosma versipellis, purple
Flower 17 parts of Chinese violet, two spend 17 parts, 35 parts of dandelion, 7 parts of Radix Codonopsis, 7 parts of the Radix Astragali, 1 part of asarum.
3. it is according to claim 1 treatment the proliferation of mammary gland medicine, it is characterized in that:By the bulk drug group of following weight portion
Into:25 parts of Radix Angelicae Sinensis, 22 parts of Ligusticum wallichii, 22 parts of the radix paeoniae rubrathe, 23 parts of the red sage root, 18 parts of peach kernel, 17 parts of Rhizoma Sparganii, 17 parts of curcuma zedoary, 22 parts of corydalis tuber,
16 parts of frankincense, 18 parts of myrrh, 17 parts of rhizoma cyperi, wear 8 parts of front three, 18 parts of sliced CORNUS CERVI, 7 parts of rhizoma typhonii, 18 parts of scarlet woollen blanket, the pinecone 18
Part, 17 parts of iron sunshade, 18 parts of luffa, 16 parts of tangerine seed, 19 parts of the root of Dahurain angelica, 19 parts of semen brassicae, 17 parts of the tuber of pinellia, 18 parts of Dysosma versipellis, purple
Flower 18 parts of Chinese violet, two spend 19 parts, 38 parts of dandelion, 9 parts of Radix Codonopsis, 9 parts of the Radix Astragali, 2 parts of asarum.
4. it is according to claim 1 treatment the proliferation of mammary gland medicine, it is characterized in that:By the bulk drug group of following weight portion
Into:27 parts of Radix Angelicae Sinensis, 27 parts of Ligusticum wallichii, 27 parts of the radix paeoniae rubrathe, 25 parts of the red sage root, 20 parts of peach kernel, 20 parts of Rhizoma Sparganii, 20 parts of curcuma zedoary, 24 parts of corydalis tuber,
22 parts of frankincense, 22 parts of myrrh, 15 parts of rhizoma cyperi, wear 5 parts of front three, 15 parts of sliced CORNUS CERVI, 10 parts of rhizoma typhonii, 18 parts of scarlet woollen blanket, the pinecone 18
Part, 25 parts of iron sunshade, 25 parts of luffa, 22 parts of tangerine seed, 22 parts of the root of Dahurain angelica, 20 parts of semen brassicae, 15 parts of the tuber of pinellia, 19 parts of Dysosma versipellis, purple
Flower 22 parts of Chinese violet, two spend 22 parts, 40 parts of dandelion, 9 parts of Radix Codonopsis, 10 parts of the Radix Astragali, 3 parts of asarum.
5. it is according to claim 1 treatment the proliferation of mammary gland medicine, it is characterized in that:By the bulk drug group of following weight portion
Into:30 parts of Radix Angelicae Sinensis, 28 parts of Ligusticum wallichii, 30 parts of the radix paeoniae rubrathe, 20 parts of the red sage root, 25 parts of peach kernel, 22 parts of Rhizoma Sparganii, 15 parts of curcuma zedoary, 25 parts of corydalis tuber,
15 parts of frankincense, 15 parts of myrrh, 23 parts of rhizoma cyperi, wear 15 parts of front three, 24 parts of sliced CORNUS CERVI, 15 parts of rhizoma typhonii, 25 parts of scarlet woollen blanket, the pinecone 25
Part, 22 parts of iron sunshade, 22 parts of luffa, 15 parts of tangerine seed, 15 parts of the root of Dahurain angelica, 25 parts of semen brassicae, 25 parts of the tuber of pinellia, 22 parts of Dysosma versipellis, purple
Flower 16 parts of Chinese violet, two spend 17 parts, 45 parts of dandelion, 15 parts of Radix Codonopsis, 12 parts of the Radix Astragali, 5 parts of asarum.
6. it is according to claim 1 treatment the proliferation of mammary gland medicine preparation method, it is characterized in that:Specifically include following step
Suddenly:
(1)By Radix Angelicae Sinensis, Ligusticum wallichii, the radix paeoniae rubrathe, the red sage root, peach kernel, Rhizoma Sparganii, curcuma zedoary, corydalis tuber, frankincense, myrrh, rhizoma cyperi, wear front three, deer horn
Piece, rhizoma typhonii, scarlet woollen blanket, the pinecone, iron sunshade, luffa, tangerine seed, the root of Dahurain angelica, semen brassicae, the tuber of pinellia, Dysosma versipellis, Chinese violet, two
Flower, dandelion, Radix Codonopsis, the Radix Astragali, asarum are put into marmite, add water 7000 milliliters it is boiled, be cooked by slow fire 1.5-2 hours, it is fried
4500-4800 milliliters of concoction;
(2), connect previous step, the concoction in previous step is poured into medicine kettle, and is put into sterile gauze pad and boiled, pad of cotion is dragged for
Go out waiting temperature for 30-50 spend when, being placed on the breast affected area of patient carries out external application, and the external application time is 30-50 minutes, daily one
It is secondary.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710037260.XA CN106692878A (en) | 2017-01-19 | 2017-01-19 | Medicine for treating mammary gland hyperplasia and preparation method of medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710037260.XA CN106692878A (en) | 2017-01-19 | 2017-01-19 | Medicine for treating mammary gland hyperplasia and preparation method of medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106692878A true CN106692878A (en) | 2017-05-24 |
Family
ID=58907795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710037260.XA Pending CN106692878A (en) | 2017-01-19 | 2017-01-19 | Medicine for treating mammary gland hyperplasia and preparation method of medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106692878A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109568479A (en) * | 2019-01-09 | 2019-04-05 | 义乌凌川科技有限公司 | A kind of Traditional Chinese medicine permeation liquid and preparation method thereof for treating the proliferation of mammary gland |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815292A (en) * | 2015-05-27 | 2015-08-05 | 沈洪彦 | Traditional Chinese medicine composition for treating lobular hyperplasia of mammary glands and breast tumor |
CN104840904A (en) * | 2015-06-12 | 2015-08-19 | 李兰珍 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
-
2017
- 2017-01-19 CN CN201710037260.XA patent/CN106692878A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815292A (en) * | 2015-05-27 | 2015-08-05 | 沈洪彦 | Traditional Chinese medicine composition for treating lobular hyperplasia of mammary glands and breast tumor |
CN104840904A (en) * | 2015-06-12 | 2015-08-19 | 李兰珍 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
Non-Patent Citations (1)
Title |
---|
窦时人等: "活血化瘀治疗乳腺增生130例", 《实用医技杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109568479A (en) * | 2019-01-09 | 2019-04-05 | 义乌凌川科技有限公司 | A kind of Traditional Chinese medicine permeation liquid and preparation method thereof for treating the proliferation of mammary gland |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705906B (en) | Chinese medicine hot compress plaster for improving microcirculation and relieving pain | |
CN102380083A (en) | External plaster for treating mammary gland hyperplasia and lactation mastitis | |
CN102908603B (en) | Chinese medicament for treating hyperplasia of mammary glands | |
CN107998341A (en) | Newborn numbness disappear medicinal powder application and production method | |
CN103623318A (en) | Traditional Chinese medicine formula ointment for removing tumor and eliminating swelling | |
CN102178817B (en) | Chinese medicinal composition for treating multiple lipomas | |
CN101897882B (en) | Medicament for treating and breast lobular hyperplasia and cyst | |
CN102973892A (en) | Traditional Chinese medicine combination for treating breast cancer | |
CN106692878A (en) | Medicine for treating mammary gland hyperplasia and preparation method of medicine | |
CN102824445A (en) | Traditional Chinese medicine composition for treating duodenal ulcer | |
CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
CN108853440A (en) | A kind of traditional Chinese medicinal ointment for treating thyroid tumors | |
CN104623450A (en) | Traditional Chinese medicine preparation for treating breast cancer | |
CN104873602A (en) | Traditional Chinese medicine for treating mammary gland hyperplasia | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN104338052A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
CN1101690C (en) | Chinese-herbal medicine for curing mastopathy | |
CN104644997A (en) | Medicine for treating lobular hyperplasia of mammary glands | |
CN104491511A (en) | Traditional Chinese medicine external-applying preparation for treating hyperplasia of mammary glands | |
CN101301412B (en) | Capsules for soothing depression and dissipating binds | |
CN103948872B (en) | Traditional Chinese medicine for treating psoriatic arthritis | |
CN114533831B (en) | Traditional Chinese medicine composition with effects of warming middle-jiao, dispelling cold, eliminating dampness, promoting blood circulation, removing obstruction in channels and relieving pain and heat-covered bag thereof | |
CN102895414B (en) | Chinese herbal paste for treating superficial cancer | |
CN101342288A (en) | Traditional Chinese medicine plaster for treating lympha, mammary gland tuberculosis and scaly tetter | |
CN104623549A (en) | Traditional Chinese medicine preparation for treating costal chondritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170524 |